↓ Skip to main content

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

Overview of attention for article published in Frontiers in oncology, December 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
Published in
Frontiers in oncology, December 2022
DOI 10.3389/fonc.2022.1016295
Pubmed ID
Authors

Angela Toss, Marta Venturelli, Monica Civallero, Claudia Piombino, Federica Domati, Guido Ficarra, Francesca Combi, Eleonora Cabitza, Federica Caggia, Elena Barbieri, Monica Barbolini, Luca Moscetti, Claudia Omarini, Federico Piacentini, Giovanni Tazzioli, Massimo Dominici, Laura Cortesi

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 15%
Librarian 1 5%
Student > Doctoral Student 1 5%
Professor 1 5%
Student > Ph. D. Student 1 5%
Other 1 5%
Unknown 12 60%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 15%
Medicine and Dentistry 2 10%
Agricultural and Biological Sciences 1 5%
Linguistics 1 5%
Immunology and Microbiology 1 5%
Other 1 5%
Unknown 11 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2022.
All research outputs
#21,330,066
of 26,181,776 outputs
Outputs from Frontiers in oncology
#11,713
of 22,924 outputs
Outputs of similar age
#369,839
of 498,975 outputs
Outputs of similar age from Frontiers in oncology
#975
of 1,505 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 498,975 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,505 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.